Boehringer Ingelheim announces European Medicines Agency』s filing acceptance and validation of marketing authorization application for spesolimab in generalized pustular psoriasis
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim announced today that the company』s marketing authorization application (MAA) for the treatment of flares in generalized pustular psoria......

